经皮冠脉介入术在高龄老年患者治疗中的研究新进展  

Study of Percutaneous Coronary Intervention in Treatment of Elderly Patients

作　　者：袁帅 王梦 毛玉琳 钱志敏 任燕霞 孙超[1,3] 梁家阳 殷惠娇 黄柳海 王大新 何胜虎 YUAN Shuai;WANG Meng;MAO Yulin;QIAN Zhimin;REN Yanxia;SUN Chao;LIANG Jiayang;YIN Huijiao;HUANG Liuhai;WANG Daxin;HE Shenghu(Dalian Medical University, Dalian 116044,Liaoning, China;Xiangya Medical College, Central South University,Changsha 410000, Hunan,China;North Jiangsu People’s Hospital, The Affiliated Hospital of Medical College,Yangzhou University, Yangzhou 225001, Jiangsu, China)

机构地区：[1]大连医科大学,辽宁大连116044 [2]中南大学湘雅医学院,湖南长沙410000 [3]扬州大学医学院附属医院苏北人民医院,江苏扬州225001

出　　处：《心血管病学进展》2019年第6期864-868,共5页Advances in Cardiovascular Diseases

基　　金：国家重大项目973计划（2007CB936104）;江苏省“六大人才高峰”(2014-SWYY-052)

摘　　要：心血管疾病,特别是缺血性心脏病,是全球高龄人群(>80岁)发病和死亡的主要原因。经皮冠脉介入术治疗的患者占现实生活发病人群中的比例>1/5,其缺血危险因素比年轻患者更多,近10年来再灌注治疗亦在老年人群中逐渐增多,现就经皮冠脉介入术在高龄患者的非ST段抬高型急性冠脉综合征、ST段抬高型心肌梗死中的应用进行综述。Cardiovascular disease, particularly ischemic heart disease,is the leading cause of morbidity and mortality in the elderly(>80 years) worldwide. The proportion of these patients who need percutaneous coronary intervention treatment in the real-life patients has been more than one fifth. Their ischemic risk factors are often more than those of their younger peers. In the past 10 years, the application of reperfusion therapy in the elderly population has gradually increased. This paper reviews the application of percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome and ST-segment elevation myocardial infarction in elderly patients.

关 键 词：老年患者 急性心肌梗死 急诊 经皮冠脉介入术 冠状动脉搭桥旁路移植术 

分 类 号：R541.4[医药卫生—心血管疾病]